Abstract:Various regulatory authorities such as the International Conference on Harmonization (ICH), the United States Food and Drug administration (FDA), and the Canadian Drug and Health Agency (CDHA) are emphasizing on the purity requirements and the identification of impurities in Active Pharmaceutical Ingredients (APIs). The various sources of impurity in pharmaceutical products are - reagents, heavy metals, ligands, catalysts, other materials like filter aids, charcoal, and the like, degraded end products obtained during \ after manufacturing of bulk drugs from hydrolysis, photolytic cleavage, oxidative degradation, decarboxylation, enantiomeric impurity, and so on. The different pharmacopoeias such as the British Pharmacopoeia, United State Pharmacopoeia, and Indian Pharmacopoeia are slowly incorporating limits to allowable levels of impurities present in APIs or formulations. Various methods are used to isolate and characterize impurities in pharmaceuticals, such as, capillary electrophoresis, electron paramagnetic resonance, gas-liquid chromatography, gravimetric analysis, high performance liquid chromatography, solid-phase extraction methods, liquid-liquid extraction method, Ultraviolet Spectrometry, infrared spectroscopy, supercritical fluid extraction column chromatography, mass spectrometry, Nuclear magnetic resonance (NMR) spectroscopy, and RAMAN spectroscopy. Among all hyphenated techniques, the most exploited techniques for impurity profiling of drugs are Liquid Chromatography (LC)-Mass Spectroscopy (MS), LC-NMR, LC-NMR-MS, GC-MS, and LC-MS. This reveals the need and scope of impurity profiling of drugs in pharmaceutical research.

Deuterated Drugs: Isotope Distribution and Impurity Profiles

Subcellular Tracking of Deuterated Drugs by Stimulated Raman Scattering Microscopy

The Kinetic Isotope Effect in the Search for Deuterated Drugs

Deuterated reagents in multicomponent reactions to afford deuterium-labeled products

Clinical Application and Synthesis Methods of Deuterated Drugs

Recent Advances in Deuteration Reactions

Designing chemical systems for precision deuteration of medicinal building blocks

Recent Developments for the Deuterium and Tritium Labeling of Organic Molecules.

Scalable and selective deuteration of (hetero)arenes

Selective Deuteration and Tritiation of Pharmaceutically Relevant Sulfoximines

Synthesis of Deuterated Compounds by Flow Chemistry

Deuterated Alkyl Sulfonium Salt Reagents; Importance of H/D Exchange Methods in Drug Discovery

Selective and Scalable Deuteration of Heteroarenes Using Nickel‐Based Nanoparticles

Recent Progresses in Analytical Perspectives of Degradation Studies and Impurity Profiling in Pharmaceutical Developments: An Updated Review

Hydrogen Isotope Labeling of Pharmaceuticals via Dual Hydrogen Isotope Exchange Pathways

Separation of isotopologues of amphetamine with various degree of deuteration on achiral and polysaccharide-based chiral columns in high-performance liquid chromatography

Catalytic Transfer Deuteration and Hydrodeuteration: Emerging Techniques to Selectively Transform Alkenes and Alkynes to Deuterated Alkanes.

Radical deuteration

Recent trends in the impurity profile of pharmaceuticals

Deuterium Editing of Small Molecules: A Case Study on Antitumor Activity of 1,4-Benzodiazepine-2,5-dione Derivatives

Alkali Metal Amide–Catalyzed Deuteration and Tritiation of Pharmaceuticals